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Abstract 
Chemotherapy is one of the most widely used treatments of various breast 
cancers; however, it has been shown that carcinoma-associated fibroblasts 
(CAFs) induce chemotherapy resistance of breast cancer cells (BCCs). Previous 
research has shown that the downregulation of caveolin-1 (cav-1), a structural 
component of membrane caveolae, promotes a CAF-like phenotype in stromal 
cells. This study was performed to evaluate the effect that downregulation of 
caveolin-1 in mammary fibroblasts imparts on chemotherapy resistance in 
BCCs. To determine the half maximal inhibitory concentration (IC50) of 
chemotherapy agents on BCCs, MDA-MB-231 (MDA) and MCF-7 BCCs were 
treated for 24 and 48 hours with doxorubicin (DOX) or tamoxifen (TAM), then 
cell viability was measured. The WST-1 cell viability assay showed significant 
cytotoxicity after 48 hours for all treatments. MDA BCCs exhibited significant cell 
death following treatment with 0.9 ug/mL of DOX and 7 uM of TAM. MCF-7 
BCC’s had significant cell death at 0.92 ug/mL for DOX and 7.5 uM for TAM; 
however, these results were less consistent when multiple assays were 
performed on MCF-7 BCCs treated with DOX. Many attempts were made to 
isolate mammary gland fibroblasts from cav-1 -/- and cav-1 +/+ mice with no 
success. Instead, human mammary fibroblasts (HMFs) were transfected with 
cav-1 shRNA to induce downregulation of cav-1 protein expression. HMFs 
transfected with cav-1 shRNA were positively selected with puromycin, then 
subcultured to ensure only transfected cells remained adherent. After a 72-hour 
growth period, protein lysate was collected and a western blot was done to 
assess cav-1 expression. Results showed a significant downregulation of cav-1 
in cav-1 shRNA treated samples. Overall, these results indicate that TAM is a 
strong cytotoxic agent against MDA and MCF-7 BCCs, while DOX is more 
effective against MDA BCCs. Also, the use of shRNA transfection proved to be a 
beneficial technique for downregulation of cav-1 in HMFs. 
Carcinoma-associated fibroblasts (CAFs) have the largest concentration of all 
cell types within the breast cancer tumor stroma and have been shown to induce 
chemotherapy resistance within multiple lines of breast cancer cells 
(Buchsbaum, R. et al.). CAFs experience a loss of cav-1 through autophagy in 
response to oxidative stress induced by breast cancer cells (Martinez-
Outschoorn, U., et al.). Loss of cav-1 in activated CAFs contributes to the 
secretion of growth factors, cytokines, and metabolites that stimulate breast 
cancer mitochondrial metabolism, decrease the pH within the breast cancer 
tumor microenvironment, and stimulate tumorigenesis (Luo, H., et al.). Previous 
research has also shown that downregulation of cav-1 promotes a CAF-like 
phenotype in stromal fibroblasts (Casazza, A., et al.). This downregulation of 
cav-1 at the protein level in stromal fibroblasts has been linked to breast cancer 
tumor progression and poor patient outcome (Sotgia, F., et al.). 
Loss of fibroblast cav-1 will induce chemotherapy resistance in breast cancer 
cells. 
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Conclusions 
These findings indicate that tamoxifen is an effective 
cytotoxic agent for both MDA and MCF-7 BCCs, while 
doxorubicin is a strong agent against MDA BCCs. Although 
murine mammary gland fibroblasts were not isolated 
despite repeated attempts, transfection of HMFs with cav-1 
shRNA was a useful tool in the downregulation of cav-1 
protein. Lastly, the HMF and MDA co-cultures suggest that 
the downregulation of cav-1 in stromal mammary fibroblasts 
may play a role in endocrine chemotherapy resistance of 
MDA-MB-231 breast cancer cells.  
